UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Precision Medicine

Precision Medicine in Rare Diseases

7% of the population will be affected by a rare disease at some point in their lives. In anticipation of the Precision Medicine & Biomarkers Leaders Summit: USA and in recognition of Rare Disease Day, we have collated some of the top articles on rare diseases and their treatments.

Read More

Highlights From The 4th Global Precision Medicine & Biomarkers Leaders Summit

With just 3 months to go until the Precision Medicine & Biomarkers Leaders Summit: USA, we have taken some time to reflect on the Euopean Precision Medicine & Biomarkers Leaders Summit that took place in Munich in September. 

Read More

The Future of Personalised Medicine, Companion Diagnostics & AI

It was a pleasure to welcome back Miro Venturi to the Global Precision & Biomarkers Leaders Summit, our keynote speaker who spoke on the future of personalised medicine and the interplay of diseases, information and technologies. After his presentation, we sat down with him to get more of an insight into his thoughts on the future.

Read More

Honey Reddi on Liquid Biopsies and her Predictions for Precision Medicine

Honey Reddi, Clinical Laboratory Director at the Jackson Laboratory spoke at the 4th Global Precision Medicine and Biomarkers Leader Summit. She gives us an insight on liquid biopsies in the clinic and the effectiveness of current treatment.

Read More

Presentation Slide Release: Strategies and Technologies to Deliver Precision Medicine

Presented at the 4th Global Precision Medicine & Biomarkers Leader Summit, these slides are now available to download and share with your colleagues.

Read More

Digital pathology and Artificial Intelligence in the precision medicine era

In 2017, technological advances in cloud computing and artificial intelligence has pathology positioned to become one of the most talked about medical fields in healthcare.

Read More

Considerations for the development of a liquid biopsy assay for cancer

Non-invasive evaluation of molecular markers has shifted from the realm of prenatal diagnosis to tracking the effect of cancer treatment and management. 

Read More

Precision medicine: the solution to the largest inefficiency in healthcare systems

Rheumatoid arthritis is one of the highest sources of the inefficiency of worldwide health care systems. This could be avoided by more tailored and individualised therapeutic strategies which require better molecular characterization of each patient.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive